openPR Logo
Press release

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of CLDA

02-23-2011 02:57 PM CET | Politics, Law & Society

Press release from: Levi & Korsinsky, LLP

Levi & Korsinsky is investigating the Board of Directors of Clinical Data, Inc. (“Clinical Data” or the “Company”) (Nasdaq: CLDA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Forest Laboratories, Inc.

New York, NY, February 23, 2011 -- Levi & Korsinsky is investigating the Board of Directors of Clinical Data, Inc. (“Clinical Data” or the “Company”) (Nasdaq: CLDA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Forest Laboratories, Inc. (“Forest”) (NYSE: FRX). Under the terms of the transaction, Clinical Data shareholders will receive $30.00 per share in cash, with a consideration of up to $6.00 contingent upon commercial milestones related to the drug Viibryd. The companies said the deal is valued at $1.2 billion net of an undisclosed amount of cash acquired.

Click here to learn more about the investigation: http://www.zlk.com/clinical-data-clda.html, or call: 877-363-5972.

The investigation concerns whether the Clinical Data Board of Directors breached their fiduciary duties to Clinical Data stockholders by failing to adequately shop the Company before entering into this transaction and whether Forest is underpaying for Clinical Data shares, thus unlawfully harming Clinical Data stockholders. In particular, at least one analyst set a price target of $46 per share of Clinical Data stock.

If you own common stock in Clinical Data and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/clinical-data-clda.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Levi & Korsinsky, LLP, Joseph Levi, Esq., Eduard Korsinsky, Esq., 30 Broad Street - 15th Floor, New York, NY 10004, Tel: (212) 363-7500, Toll Free: (877) 363-5972, Fax: (212) 363-7171, www.zlk.com

Contact:
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
http://www.zlk.com

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation

Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
http://www.zlk.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of CLDA here

News-ID: 163714 • Views:

More Releases from Levi & Korsinsky, LLP

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Se …
Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of China Automotive Systems, Inc. (“China Automotive” or the “Company”) (Nasdaq: CAAS) concerning possible violations of federal securities laws. New York, NY, March 24, 2011 -- Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of China Automotive Systems, Inc. (“China Automotive” or the “Company”) (Nasdaq: CAAS) concerning possible violations of federal
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Vi …
Levi & Korsinsky, LLP is investigating TETRA Technologies, Inc. (NYSE: TTI), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming May 3, 2011 shareholder vote. New York, NY, March 23, 2011 -- Levi & Korsinsky, LLP is investigating TETRA Technologies, Inc. (NYSE: TTI), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming May 3, 2011
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Vi …
Levi & Korsinsky, LLP is investigating Cincinnati Financial Corporation (“Cincinnati Financial” or the “Company”) (NASDAQ: CINF), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming April 30, 2011 shareholder vote. New York, NY, March 22, 2011 -- Levi & Korsinsky, LLP is investigating Cincinnati Financial Corporation (“Cincinnati Financial” or the “Company”) (NASDAQ: CINF), and its Board of Directors, for possible violations of federal
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Se …
Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Kid Brands, Inc. (NYSE: KID) concerning possible violations of federal securities laws. New York, NY, March 22, 2011 -- Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Kid Brands, Inc. (NYSE: KID) concerning possible violations of federal securities laws. On March 15, 2011, Kid Brands announced it would delay the

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical